000			01968 a2200517 4500
005			20250516003824.0
264		0	_c20120313
008			201203s 0 0 eng d
022			_a1558-1497
024	7		_a10.1016/j.neurobiolaging.2010.08.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aVillar-Cheda, Begoña
245	0	0	_aAging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration. _h[electronic resource]
260			_bNeurobiology of aging _cJan 2012
300			_a204.e1-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAging _xmetabolism
650	0	4	_aAngiotensin II _xphysiology
650	0	4	_aAngiotensin II Type 1 Receptor Blockers _xpharmacology
650	0	4	_aAnimals
650	0	4	_aBenzimidazoles _xpharmacology
650	0	4	_aBiphenyl Compounds
650	0	4	_aDopaminergic Neurons _xmetabolism
650	0	4	_aInflammation Mediators _xmetabolism
650	0	4	_aInterleukin-1beta _xmetabolism
650	0	4	_aMale
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNADPH Oxidases _xmetabolism
650	0	4	_aNerve Degeneration
650	0	4	_aOxidative Stress
650	0	4	_aOxidopamine _xpharmacology
650	0	4	_aParkinson Disease _xetiology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aReceptor, Angiotensin, Type 1 _xphysiology
650	0	4	_aSubstantia Nigra _xmetabolism
650	0	4	_aTetrazoles _xpharmacology
650	0	4	_aTumor Necrosis Factor-alpha _xmetabolism
700	1		_aValenzuela, Rita
700	1		_aRodriguez-Perez, Ana I
700	1		_aGuerra, Maria J
700	1		_aLabandeira-Garcia, Jose L
773	0		_tNeurobiology of aging _gvol. 33 _gno. 1 _gp. 204.e1-11
856	4	0	_uhttps://doi.org/10.1016/j.neurobiolaging.2010.08.006 _zAvailable from publisher's website
999			_c20216106 _d20216106